IE35437L - Vaccine from bacteroides nodosus. - Google Patents
Vaccine from bacteroides nodosus.Info
- Publication number
- IE35437L IE35437L IE710859A IE85971A IE35437L IE 35437 L IE35437 L IE 35437L IE 710859 A IE710859 A IE 710859A IE 85971 A IE85971 A IE 85971A IE 35437 L IE35437 L IE 35437L
- Authority
- IE
- Ireland
- Prior art keywords
- vaccine
- bacteroides nodosus
- july
- infection
- antigens
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 241000605721 Dichelobacter nodosus Species 0.000 title abstract 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- 229930064664 L-arginine Natural products 0.000 abstract 1
- 235000014852 L-arginine Nutrition 0.000 abstract 1
- 241001494479 Pecora Species 0.000 abstract 1
- 241000282849 Ruminantia Species 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract 1
- 239000001569 carbon dioxide Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002609 medium Substances 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
1351343 Vaccine preparation NEW ZEALAND INVENTIONS DEVELOPMENT AUTHORITY 6 July 1971 [6 July 1970] 31684/71 Heading A5B [Also in Division C6] A process for preparing a vaccine effective against Bacteroides nodosus Beveridge (Mraz) infection in sheep and other ruminant animals involves anaerobically cultivating the microorganisms in the presence of carbon dioxide in a nutrient culture medium containing separately added L-arginine or a salt thereof e.g. the monohydrochloride, recovering from the cultured medium antigens that induce protection against Bacteroides nodosus infection and incorporating the recovered protective antigens in a vaccine in a conventional manner. The vaccines may be prepared from the bacterial cells, the supernatant fluid or the two combination.
[GB1351343A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ16072770 | 1970-07-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE35437L true IE35437L (en) | 1972-01-06 |
| IE35437B1 IE35437B1 (en) | 1976-02-18 |
Family
ID=19916692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE859/71A IE35437B1 (en) | 1970-07-06 | 1971-07-06 | Improvements in or relating to methods of preparation and use of a vaccine from bacteroides nodosus |
Country Status (7)
| Country | Link |
|---|---|
| CA (1) | CA947198A (en) |
| DE (1) | DE2133654A1 (en) |
| FR (1) | FR2100868B1 (en) |
| GB (1) | GB1351343A (en) |
| IE (1) | IE35437B1 (en) |
| SU (1) | SU379102A3 (en) |
| ZA (1) | ZA714355B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU529322B2 (en) * | 1979-07-27 | 1983-06-02 | Pitman-Moore, Inc. | Antigenic compositions |
| US4737363A (en) * | 1984-12-24 | 1988-04-12 | Commonwealth Scientific And Industrial Research Organization | Bacteroides nodosus vaccine |
-
1971
- 1971-07-02 ZA ZA714355A patent/ZA714355B/en unknown
- 1971-07-05 SU SU1677854A patent/SU379102A3/ru active
- 1971-07-06 IE IE859/71A patent/IE35437B1/en unknown
- 1971-07-06 FR FR7124658A patent/FR2100868B1/fr not_active Expired
- 1971-07-06 DE DE19712133654 patent/DE2133654A1/en active Pending
- 1971-07-06 CA CA117,434A patent/CA947198A/en not_active Expired
- 1971-07-06 GB GB3168471A patent/GB1351343A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2133654A1 (en) | 1972-01-13 |
| FR2100868B1 (en) | 1974-09-06 |
| SU379102A3 (en) | 1973-04-18 |
| IE35437B1 (en) | 1976-02-18 |
| ZA714355B (en) | 1972-03-29 |
| FR2100868A1 (en) | 1972-03-24 |
| GB1351343A (en) | 1974-04-24 |
| CA947198A (en) | 1974-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8202584A1 (en) | Stabilizer for liquid vaccines and liquid vaccine containing said stabilizer. | |
| GB1522006A (en) | Feline calicivirus vaccine and a process for the production thereof | |
| GB1121308A (en) | Cephalosporins | |
| IE35437L (en) | Vaccine from bacteroides nodosus. | |
| JPS5299289A (en) | Preparation of l-arginine by fermentation | |
| GB1207781A (en) | A process for the cultivation of hemolytic streptococci | |
| GB1434582A (en) | Animal feed supplements | |
| GB1303560A (en) | ||
| GB1156387A (en) | Milk Coagulating Enzyme and method of preparation thereof | |
| GB1100190A (en) | Somatic antigen vaccines | |
| JPS5518449A (en) | Increasing method of phycocyanin yield | |
| GB1114143A (en) | Cell lines and the cultivation of viruses therein | |
| JPS5692789A (en) | Fungus polyamine oxidase pc-3 and its preparation | |
| GB1146626A (en) | Process for the manufacture of an active anticancer substance | |
| GB1147229A (en) | Process for producing l-lysine from 5-(4-aminobutyl)-hydantoin | |
| SU611597A3 (en) | Method of cultivating streptococcus hemolyticus | |
| JPS5692788A (en) | Fungus polyamine oxidase at-1 | |
| GB1436323A (en) | Cell and virus culture systems | |
| IE33734L (en) | Antigenic material | |
| SU738398A1 (en) | Culture medium for culturing pestilential microbe | |
| UA41546A (en) | Method for preparing vaccine against streptococcal and/or staphylococcal infections in animals | |
| GB901433A (en) | Pulpy kidney disease/tetanus/lamb dysentery vaccine | |
| GB1036621A (en) | Improvements in or relating to bacterial vaccines | |
| GB1152934A (en) | Process for the Production of a Vaccine Against Foot and Mouth Disease | |
| GB1215786A (en) | Process for producing l-asparaginase |